David J Vigerust

1.3k total citations
25 papers, 1.0k citations indexed

About

David J Vigerust is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, David J Vigerust has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in David J Vigerust's work include Influenza Virus Research Studies (4 papers), Hemoglobin structure and function (3 papers) and Glycosylation and Glycoproteins Research (2 papers). David J Vigerust is often cited by papers focused on Influenza Virus Research Studies (4 papers), Hemoglobin structure and function (3 papers) and Glycosylation and Glycoproteins Research (2 papers). David J Vigerust collaborates with scholars based in United States and Australia. David J Vigerust's co-authors include Virginia L. Shepherd, Jonathan A. McCullers, Samuel Hawgood, Jens Madsen, Kelli L. Boyd, Kimberly B. Ulett, Karen Graves, Pierre P. Leimgruber, Doris L. Lefkowitz and Steven R. Fuhrmann and has published in prestigious journals such as Journal of Virology, Clinical Chemistry and Nutrients.

In The Last Decade

David J Vigerust

24 papers receiving 1.0k citations

Peers

David J Vigerust

EPIDE

IMMUN

VIROL

Ralf Spallek Germany

Mohsan Saeed United States

Yonggang Li China

Chikako Ono Japan

Asma Ahmed India

Anuradha Chakraborti India

Guangli Wang China

Eun‐Kyung Moon South Korea

Megan Steain Australia

Linbai Ye China

Ralf Spallek Germany

David J Vigerust

354 ×0.9

EPIDE

401 ×1.2

451 ×1.7

471 ×2.1

IMMUN

72 ×0.9

VIROL

Citations per year, relative to David J Vigerust David J Vigerust (= 1×) peers Ralf Spallek

Countries citing papers authored by David J Vigerust

Since Specialization

Citations

This map shows the geographic impact of David J Vigerust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J Vigerust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J Vigerust more than expected).

Fields of papers citing papers by David J Vigerust

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J Vigerust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J Vigerust. The network helps show where David J Vigerust may publish in the future.

Co-authorship network of co-authors of David J Vigerust

This figure shows the co-authorship network connecting the top 25 collaborators of David J Vigerust. A scholar is included among the top collaborators of David J Vigerust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J Vigerust. David J Vigerust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vigerust, David J. (2024). B-230 Rt-pcr detection and monitoring of infection in periodontal disease: a model of herpesviral-bacterial synergism. Clinical Chemistry. 70(Supplement_1). 1 indexed citations

Li, Feng, Tristan Grogan, David Elashoff, et al.. (2022). Proficiency Testing of Epidermal Growth Factor Receptor Mutations Detection in Saliva Using Spectrum Saliva Collector (SDNA-1000) and Preservative Solution Detected by Electric Field-Induced Release and Measurement. Biopreservation and Biobanking. 20(5). 461–464. 1 indexed citations

Leimgruber, Pierre P., et al.. (2022). The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress. Frontiers in Cardiovascular Medicine. 9. 1042729–1042729. 23 indexed citations

Vigerust, David J, et al.. (2020). Enhancement of Innate Immunity to COVID-19 with Natural Measures. 16(3). 1–4. 1 indexed citations

Vigerust, David J, et al.. (2020). Cardiovascular Prevention: Migrating From a Binary to a Ternary Classification. Frontiers in Cardiovascular Medicine. 7. 92–92. 3 indexed citations

Vigerust, David J, et al.. (2020). Microvascular disease confers additional risk to COVID-19 infection. Medical Hypotheses. 144. 109999–109999. 4 indexed citations

Vigerust, David J, et al.. (2018). Precision Healthcare of Type 2 Diabetic Patients Through Implementation of Haptoglobin Genotyping. Frontiers in Cardiovascular Medicine. 5. 141–141. 17 indexed citations

Vigerust, David J. (2016). Clinical importance of haptoglobin testing in diabetes. Diabetes Management. 6(5). 95–98. 1 indexed citations

Vigerust, David J. (2016). Neuroinflammation: a precursor and promoter of oncogenesis. Future Neurology. 11(2). 113–117.

10.

Graves, Karen & David J Vigerust. (2016). Hp: an Inflammatory Indicator in Cardiovascular Disease. Future Cardiology. 12(4). 471–481. 24 indexed citations

11.

Vigerust, David J, et al.. (2015). Stable Expression and Characterization of an Optimized Mannose Receptor. Journal of Clinical & Cellular Immunology. 6(3). 10 indexed citations

12.

Yang, Seungchan, David J Vigerust, & Virginia L. Shepherd. (2013). Interaction of members of the heat shock protein-70 family with the macrophage mannose receptor. Journal of Leukocyte Biology. 93(4). 529–536. 7 indexed citations

13.

Vigerust, David J, et al.. (2012). Characterization of functional mannose receptor in a continuous hybridoma cell line. BMC Immunology. 13(1). 51–51. 22 indexed citations

14.

Vigerust, David J. (2011). Protein glycosylation in infectious disease pathobiology and treatment. Open Life Sciences. 6(5). 802–816. 16 indexed citations

15.

Vigerust, David J, et al.. (2009). Mitogen-activated protein kinases and NFκB are involved in SP-A-enhanced responses of macrophages to mycobacteria. Respiratory Research. 10(1). 60–60. 4 indexed citations

16.

Vigerust, David J, Kimberly B. Ulett, Kelli L. Boyd, et al.. (2007). N-Linked Glycosylation Attenuates H3N2 Influenza Viruses. Journal of Virology. 81(16). 8593–8600. 146 indexed citations

17.

Vigerust, David J & Virginia L. Shepherd. (2007). Virus glycosylation: role in virulence and immune interactions. Trends in Microbiology. 15(5). 211–218. 472 indexed citations

18.

Vigerust, David J & Jonathan A. McCullers. (2007). Chloroquine is effective against influenza A virus in vitro but not in vivo. Influenza and Other Respiratory Viruses. 1(5-6). 189–192. 57 indexed citations

19.

Vigerust, David J, et al.. (2005). HIV-1 Nef mediates post-translational down-regulation and redistribution of the mannose receptor. Journal of Leukocyte Biology. 77(4). 522–534. 36 indexed citations

20.

Gelderman, Monique P., David J Vigerust, Steven R. Fuhrmann, et al.. (1998). Perpetuation of inflammation associated with experimental arthritis: the role of macrophage activation by neutrophilic myeloperoxidase. Mediators of Inflammation. 7(6). 381–389. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact